Ultrasonic quantitative evaluation and grading diagnosis of metabolically associated fatty liver disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300069892

Enrollment

Unknown

Registered

2023-03-28

Start date

2023-04-01

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic associated fatty liver disease

Interventions

Group MAFLD (TAI, TSI, MRI, SWE, CAP, US):None

Group LRYGB (TAI, TSI):

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) aged between 18 years old and 85 years old; 2) known NAFLD or suspected of having NAFLD; 3) willingness and ability to participate

Exclusion criteria

Exclusion criteria: 1)aged 85 years old; 2) clinical, laboratory, or histologic evidence of a liver disease other than NAFLD; 3) excessive alcohol consumption (?14 and ?7 drinks per week for men and women, respectively); 4) Previous liver surgery; 5) MRI contraindications (due to claustrophobia, metal implants, or body circumference beyond the aperture of the MRI scanner); 6) Major systemic diseases

Design outcomes

Primary

Measure	Time frame
AC-TAI;SC-TSI;	—

Secondary

Measure	Time frame
CAP;MRI-PDFF;	—

Countries

China

Contacts

Public ContactSundi

Shanghai Jiao Tong University School Of Medicine Affiliated Sixth People's Hospital

Sundy316@163.com+86 18930172830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026